GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have earned an average recommendation of “Moderate Buy” from the eleven brokerages that are presently covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $88.5455.

Several brokerages recently weighed in on GEHC. BTIG Research reaffirmed a “buy” rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Evercore ISI lowered their price target on GE HealthCare Technologies from $96.00 to $85.00 and set an “outperform” rating for the company in a report on Thursday, May 1st. Wells Fargo & Company lowered their price target on GE HealthCare Technologies from $103.00 to $89.00 and set an “overweight” rating for the company in a report on Thursday, May 1st. Wall Street Zen upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating in a report on Saturday, May 31st. Finally, UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lowered their price target for the company from $74.00 to $73.00 in a report on Monday, May 5th.

GE HealthCare Technologies Trading Up 2.8%

Shares of GEHC opened at $75.22 on Friday. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. The firm has a market capitalization of $34.34 billion, a P/E ratio of 15.41, a price-to-earnings-growth ratio of 2.80 and a beta of 1.13. The stock’s fifty day simple moving average is $74.00 and its 200 day simple moving average is $75.22. GE HealthCare Technologies has a twelve month low of $57.65 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.15. The business had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period last year, the company posted $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, equities research analysts forecast that GE HealthCare Technologies will post 4.68 earnings per share for the current year.

GE HealthCare Technologies announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, April 30th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the company to repurchase up to 3.1% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s management believes its shares are undervalued.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 25th were issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date was Friday, July 25th. GE HealthCare Technologies’s dividend payout ratio is currently 2.87%.

Institutional Trading of GE HealthCare Technologies

Large investors have recently added to or reduced their stakes in the stock. Susquehanna Fundamental Investments LLC acquired a new stake in GE HealthCare Technologies in the 4th quarter valued at $20,891,000. Breakwater Capital Group acquired a new position in GE HealthCare Technologies in the first quarter valued at approximately $210,000. Bessemer Group Inc. boosted its stake in GE HealthCare Technologies by 24.3% in the first quarter. Bessemer Group Inc. now owns 6,671 shares of the company’s stock valued at $538,000 after acquiring an additional 1,306 shares during the period. Flagship Harbor Advisors LLC boosted its stake in GE HealthCare Technologies by 17.4% in the first quarter. Flagship Harbor Advisors LLC now owns 3,443 shares of the company’s stock valued at $278,000 after acquiring an additional 511 shares during the period. Finally, Wealth Enhancement Advisory Services LLC raised its holdings in shares of GE HealthCare Technologies by 23.8% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 50,859 shares of the company’s stock valued at $4,105,000 after buying an additional 9,769 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.